Home > Insider Trading > Filing (0001209191-21-046030)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576885	Acumen Pharmaceuticals Inc.	ABOS	Biological Products, (No Disgnostic Substances) (2836)	364108129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709418	Iii A John Stalfort	C/O Acumen Pharmaceuticals, Inc. 427 Park Street Charlottesville VA 22902		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-06	130,180	$0.00	137,324	No	4	C	Direct
Common Stock	Acquisiton	2021-07-06	35,000	$16.00	172,324	No	4	P	Direct
Common Stock	Acquisiton	2021-07-06	131,595	$0.00	131,595	No	4	C	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct
No	4	C	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred	Disposition	2021-07-06	130,180	$0.00	130,180	$0.00
Common Stock	Series B Preferred	Disposition	2021-07-06	131,595	$0.00	131,595	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Indirect

Footnotes

On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and each share of Series B Convertible Preferred Stock converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as ofOctober 25, 2018.